Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 24

Results For "MIT"

6599 News Found

Parexel biotech incubator to connect early-stage innovation with clinical development expertise
Clinical Trials | June 23, 2026

Parexel biotech incubator to connect early-stage innovation with clinical development expertise

The incubator anchored at the company's global headquarters in Raleighla launches alongside an inaugural partnership with Cape Fear BioCapital, a Durham-based seed-stage venture capital firm


KIMS Hospitals Bengaluru launches KIMS RENOVA Oncology Institute
Hospitals | June 23, 2026

KIMS Hospitals Bengaluru launches KIMS RENOVA Oncology Institute

Advanced comprehensive oncology centre was inaugurated by the legendary former Indian cricketer VVS Laxman


BioMed X and Biogen launch global neuroimmunology research challenge
R&D | June 23, 2026

BioMed X and Biogen launch global neuroimmunology research challenge

Initiative seeks innovative experimental and computational approaches to uncover neural circuits regulating immune function and identify novel therapeutic targets


Pfizer lung cancer drug misses key survival goal in Phase 3 trial
Clinical Trials | June 23, 2026

Pfizer lung cancer drug misses key survival goal in Phase 3 trial

The company said the safety profile remained consistent with earlier studies and was considered manageable


Girls with ADHD from deprived backgrounds face sharply higher risk of long-term health conditions: Study
Healthcare | June 23, 2026

Girls with ADHD from deprived backgrounds face sharply higher risk of long-term health conditions: Study

The research underscores growing concern that the intersection of neurodevelopmental conditions and social disadvantage can significantly compound health risks across the life course


Teva closes $700M Emalex acquisition
News | June 23, 2026

Teva closes $700M Emalex acquisition

Bolstering neuroscience push with late-stage Tourette therapy


India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
interviews | June 22, 2026

India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India

Country’s deep scientific talent pool and its growing role as a clinical trial destination makes it central to how Parexel serves sponsors


Biopharma funding rebounds in 2026, but capital flows to lower-risk assets
Biopharma | June 22, 2026

Biopharma funding rebounds in 2026, but capital flows to lower-risk assets

M&A activity, IPOs and late-stage investments gain momentum as investors prioritize clinical validation, while early-stage biotech firms continue to face funding challenges


Saurabh Gambhir elevated to Chief Strategy Officer (Global) at Cipla
People | June 22, 2026

Saurabh Gambhir elevated to Chief Strategy Officer (Global) at Cipla

Prior to joining Cipla, Gambhir built a strong track record across the pharmaceutical and healthcare sectors.


MICK Digital empanelled as AMTZ authorized channel partner
Medical Device | June 22, 2026

MICK Digital empanelled as AMTZ authorized channel partner

Partnership strengthens healthcare technology distribution capabilities, enabling wider reach of Make-in-India medical devices through government and institutional healthcare networks